Patient-specific (endogenous) and population-specific (exogenous) risk fact
or analysis is identifying novel physical and chemical exposures which migh
t be time-linked to the development of amyotrophic lateral sclerosis (ALS)
and other motor neuron diseases. Electric injury in a number of case-contro
l studies as well as prolonged exposure at work and home to agricultural ch
emicals in pesticides and herbicides have been identified as significant ri
sk factors. Heavy exercise, trauma with or without bone fractures and heavy
metal exposure at work have not been confirmed as risk factors. Surprising
ly, occupation as a pilot or navigator has recently been identified as a po
tential risk factor, which will need to be confirmed. The introduction of i
nternational patient registries in North America (ALS CARE) and in Europe (
ALS HPS) will facilitate future studies on the prognosis of ALS, adherence
to standards of practice, quality of life and patient outcome studies. An i
nitial survey of the ALS Patient Care Database in January 1999, when nearly
1800 patients had been entered across North America, indicated the median
time from ALS onset to diagnosis is 14 months when no second opinion is req
uested, 13. months if the patient requests a second opinion and 10 months w
hen the neurologist requests an additional opinion. No significant differen
ce was found in the median time to diagnose sporadic ALS patients compared
with familial ALS patients.